SML2650

T3-CLK

≥98% (HPLC)

• Synonim(y): 4-(2-Methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl)-N-(6-(pyridin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide, 4-[1,1-Dimethyl-2-(4-methyl-1-piperazinyl)-2-oxoethyl]-N-[6-(4-pyridinyl)imidazo[1,2-a]pyridin-2-yl]benzamide, T3
• Wzór empiryczny (zapis Hilla): C₂₈H₃₀N₆O₂
• Numer CAS: 2109805-56-1
• Masa cząsteczkowa: 482.58
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD31689325
• Assay: ≥98% (HPLC)
• Form: powder
• Quality level: 100

Właściwości

• Quality Level: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear (warmed)
• storage temp.: room temp
• SMILES string: [n]21c(nc(c2)NC(=O)c4ccc(cc4)C(C)(C)C(=O)N5CCN(CC5)C)ccc(c1)c3ccncc3
• InChI: 1S/C28H30N6O2/c1-28(2,27(36)33-16-14-32(3)15-17-33)23-7-4-21(5-8-23)26(35)31-24-19-34-18-22(6-9-25(34)30-24)20-10-12-29-13-11-20/h4-13,18-19H,14-17H2,1-3H3,(H,31,35)
• InChI key: IEFFSHLHNYVSEF-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

T3-CLK (T3) is a cell permeable, highly potent and selective cell-base stable inhibitor of CDC-like kinase (CLK) that exhibits dose-dependent alternative splicing effects in HCT116 colorectal cancer cells. T3-CLK increases conjoined gene (CG) transcription.

cell permeable, highly potent and selective cell-base stable inhibitor of CDC-like kinase (CLK)

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable